"Expert physicians offering a variety of treatments and services for a broad range of medical conditions."

During the past decade, Keck Medical Center of USC Pasadena conducted 64 clinical trials. In the 10-year time frame, 64 clinical trials started and 19 clinical trials were completed, i.e. on average, 29.7% percent of trials that started reached the finish line to date. In the past 5 years, 17 clinical trials started and 18 clinical trials were completed. i.e. 105.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Keck Medical Center of USC Pasadena" #1 sponsor was "National Cancer Institute (NCI)" with 36 trials, followed by "SWOG Cancer Research Network" with 10 trials sponsored, "Alliance for Clinical Trials in Oncology" with 8 trials sponsored, "Pfizer" with 6 trials sponsored and "NRG Oncology" with 6 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Keck Medical Center of USC Pasadena" #1 collaborator was "National Cancer Institute (NCI)" with 28 trials as a collaborator, "Canadian Cancer Trials Group" with 5 trials as a collaborator, "Eli Lilly and Company" with 2 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 2 trials as a collaborator and "Bayer" with 1 trials as a collaborator. Other collaborators include 5 different institutions and companies that were collaborators in the rest 15 trials.

According to Clinical.Site data, the most researched conditions in "Keck Medical Center of USC Pasadena" are "Invasive Breast Carcinoma" (5 trials), "Stage IV Bladder Urothelial Carcinoma AJCC v7" (5 trials), "Metastatic Ureter Urothelial Carcinoma" (4 trials), "Stage III Bladder Urothelial Carcinoma AJCC v6 and v7" (4 trials) and "Metastatic Bladder Urothelial Carcinoma" (3 trials). Many other conditions were trialed in "Keck Medical Center of USC Pasadena" in a lesser frequency.

Most popular intervention types in "Keck Medical Center of USC Pasadena" are "Drug" (53 trials), "Other" (36 trials), "Biological" (23 trials), "Procedure" (20 trials) and "Radiation" (4 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (21 trials), "Biospecimen Collection" (12 trials), "Computed Tomography" (11 trials), "Quality-of-Life Assessment" (10 trials) and "Questionnaire Administration" (8 trials). Other intervention names were less common.

The vast majority of trials in "Keck Medical Center of USC Pasadena" are 60 trials for "All" genders, 7 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Keck Medical Center of USC Pasadena". undefined are not yet recruiting, 25 are recruiting, 27 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Keck Medical Center of USC Pasadena, 4 suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Keck Medical Center of USC Pasadena, 12 "Phase 1" clinical trials were conducted, 35 "Phase 2" clinical trials and 23 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".